VerifiedFreedom Diagnostics
99.81%
Purity
Passed full QC panel
- Variant
- Tesamorelin 10mg
- Lot
- T1001
- Net Peptide Content
- 11.72 mg
- Endotoxin
- Passed
- Heavy Metals
- Passed
- Lab
- Freedom Diagnostics
← Back to Research Library
Valence Labs Research
Tesamorelin
Growth Hormone Research Peptide
- Compound
- Tesamorelin
- Category
- Research Peptide
- Available Variant
- 10mg
- Research Status
- Research Use Only
Overview
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH). Research involving tesamorelin examines stimulation of the growth hormone pathway and downstream IGF-1 signaling.
Human clinical studies have investigated tesamorelin in relation to visceral adipose tissue, body composition, liver fat, lipid metabolism, and other metabolic markers.
Research Areas
GHRH Signaling
Tesamorelin is studied for its interaction with the growth hormone-releasing hormone pathway.
GH / IGF-1 Axis
Research examines downstream changes in growth hormone and IGF-1 signaling.
Visceral Adipose Tissue
Randomized human studies have examined changes in visceral adipose tissue in specific clinical populations.
Body Composition
Changes in body composition are another major area of tesamorelin research.
Liver & Lipid Metabolism
Clinical research has also examined liver fat, lipid measurements, and related metabolic markers.
How It Is Being Studied
Tesamorelin has been evaluated in randomized human clinical studies, giving its primary research areas direct human evidence.
This page summarizes published research contexts. It does not present the Valence Labs catalog product as an approved therapeutic or provide treatment recommendations.
Specifications
Catalog details for this product.
- Product Name
- Tesamorelin
- Category
- Research Peptide
- Variant
- 10mg
- Form
- Documentation pending
- Storage
- Documentation pending
- Purity
- Documentation pending
- Intended Use
- Laboratory research use only
Available Documentation
Certificates of Analysis
VerifiedFreedom Diagnostics
99.41%
Purity
Passed full QC panel
- Variant
- Tesamorelin 20mg
- Lot
- T2001
- Net Peptide Content
- 19.69 mg
- Endotoxin
- Passed
- Heavy Metals
- Passed
- Lab
- Freedom Diagnostics
References
- Stanley et al. — Effect of Tesamorelin on Visceral Fat and Liver Fat in HIV-Infected Patients With Abdominal Fat Accumulation
JAMA
Available Product
Tesamorelin
10mg